Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ultraviolet-A photons are electromagnetic radiation in the wavelength range of 320–400 nm, constituting the longest-wavelength and most abundant component of ultraviolet light reaching the Earth's surface[2][3]. UVA photons are not molecules or biological receptors but physical energy quanta. Their biological effects are mediated by absorption into various cellular chromophores (e.g., DNA, proteins, lipids), leading to the generation of reactive oxygen species, DNA lesions (including thymine dimers), and activation or inhibition of numerous cell signaling pathways[1][2][3][5][6][7]. UVA exposure is strongly implicated in skin photoaging, pigmentary changes, immunosuppression, and carcinogenesis. It can also modulate systemic neuroendocrine signaling after exposure through the skin or the eye[4][6]. Due to their energy being lower than UVB or UVC, UVA photons tend to cause indirect DNA damage and oxidative stress, but their deep tissue penetration allows them to target dermal structures, leading to complex biological consequences, especially upon chronic or high-dose exposure[2][3][5][7]. **Note:** - "UVA photons" is not a molecular or receptor target in the traditional therapeutic context, but rather a physical agent (form of light energy) that acts *on* biological targets[1][2][3][5][6][7]. - "Is_incorrect" is set to true because UVA photons are not a conventional drug target, receptor, enzyme, ion channel, or biomolecule, but rather a classification of electromagnetic radiation. - All effects, roles, and mechanisms described are a result of UVA photon interaction with biological substrates, not direct molecular targeting like for a protein or receptor.
None (not a classical target—UVA photons induce biological effects primarily by generating reactive oxygen species, damaging DNA and proteins, and modulating signaling via absorption by endogenous chromophores[1][2][3][5][6][7])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ultraviolet-A photon (UVA photon).